New device for delivering anti-inflammatory medication to the lungs for pain relief in COPD patients
Official title: A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)
Funded at Scientific Horizons Consulting LLC · NIH-10819739 · Data updated 2026-11-12
This study is testing a new inhaler that delivers anti-inflammatory medicine straight to the deep parts of the lungs for people with COPD, helping to reduce pain and improve breathing by using smart technology to track the right dose for each person.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scientific Horizons Consulting LLC NIH-funded |
| Lab location | 1 site (Irvine, UNITED STATES) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $274,875 |
| NIH project number | 1R43HL172316-01 |
| Project ID | NIH-10819739 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD) who experience pain related to lung inflammation.
✕Less likely to help
Patients with COPD who do not experience significant pain or have contraindications to anti-inflammatory medications may not benefit from this research.
What this research studies
This research focuses on developing a novel inhalation device designed to deliver anti-inflammatory medications directly to the deep lung areas affected by chronic obstructive pulmonary disease (COPD). The device uses advanced aerosolization technology to create optimized particle sizes for effective delivery, overcoming limitations of current inhalation methods. It features a built-in monitoring system that tracks dosage in real-time, allowing for personalized treatment. By targeting inflammation in the distal airways, this approach aims to alleviate pain associated with COPD.
Why it matters
Potential benefit: If successful, this research could significantly improve pain management for patients with COPD by providing more effective delivery of anti-inflammatory treatments.
How similar studies have gone: While the approach of using aerosolized anti-inflammatory agents is established, the specific technology and device being developed in this research is novel and has not been widely tested.
Where this research is happening
-
Scientific Horizons Consulting LLC
Irvine, United States Active
Researchers
- Principal investigator: Gao, Xiang — Scientific Horizons Consulting LLC
- Study coordinator: Gao, Xiang
Related research
Other NIH-funded projects on the same topics.
-
A new inhaler for delivering anti-inflammatory medication to help manage pain in COPD patients
This study is testing a new, easy-to-use inhaler that delivers medicine directly to the deep parts of the lungs for people with COPD, aiming to help reduce inflammation and improve comfort.
-
Ethics-aware Multimodal AI for COPD prevention, diagnosis, and treatment
A broad AI model uses diverse health data to help predict and manage COPD in people, with an emphasis on ethics and fairness.
-
ANT2 and mitochondrial dysfunction in COPD: how energy transport affects lung repair
This project studies how a key mitochondrial transporter (ANT2) may drive aging-like cell changes and repair problems in the lungs of people with COPD.
-
Muscle weakness from high carbon dioxide in COPD
Looks at whether boosting muscle energy production helps people with COPD who retain too much carbon dioxide.
-
Video Telehealth pulmonary rehab to cut COPD readmissions
A telehealth pulmonary rehabilitation program delivered by video is being tested to help people with COPD stay out of the hospital.
-
Mobile 1/2 Video Telehealth Pulmonary Rehab to Cut COPD Readmissions
A remote pulmonary rehab program delivered via video aims to help people with COPD reduce hospital readmissions and improve daily living.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.